Health Condition 1: E11- Type 2 diabetes mellitus
Conditions
Interventions
Intervention1: IV insulin infusion,: First group will receive basal bolus subcutaneous insulin, at ADA recommended dose of 0.3 to 0.6 units per kg with 50 percent of total daily dose given as basal an
Sponsors
Kalinga institute of medical sciences
Eligibility
Inclusion criteria
Inclusion criteria: All inpatients with type 2 Diabetes aged more than or equal to 18years presenting with hyperglycemia
Exclusion criteria
Exclusion criteria: Patients requiring ICU admission Patients presenting with DKA or HHS Hemodynamic instability sepsis Acute coronary syndrome Gestational diabetes Patients on TPN Patients on steroid therapy Patients with EGFR less than 30 ml per min Patients with DCLD that is Child pugh B and C Type 1 Diabetes
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the time taken to achieve the target blood glucose 100 to 180mg per dl between basal bolus regimen and IV insulin infusion in non critical patients. Target blood glucose is said to be achieved if blood glucose fluctuations remains within target for 6 continuous hoursTimepoint: At the time of admission and hourly capillary blood glucose will be monitored until target blood glucose is achieved | — |
Secondary
| Measure | Time frame |
|---|---|
| To note incidence of hypoglycemia episodes between basal bolus regimen & IV insulin infusion in non critical patients To study the total insulin dose required to achieve target blood glucose To compare glycemic variability indices between 2 arms Timepoint: At the time of admission & hourly capillary blood glucose will be monitored till the target blood glucose is achieved | — |
Countries
India
Contacts
Public ContactDr Arun Kumar Choudhury
Kalinga institute of medical sciences
Outcome results
None listed